Hypoglycemia and Dementia
Sang Youl Rhee (Rhee SY)
Endocrinol Metab. 2017;32(2):195-199.   Published online 2017 Jun 23     DOI: https://doi.org/10.3803/EnM.2017.32.2.195
Citations to this article as recorded by Crossref logo
The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms
Konstantinos N Fountoulakis, Stephen M Stahl
Journal of Psychopharmacology.2022; 36(4): 428.     CrossRef
The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia
Konstantinos N. Fountoulakis, Hans-Jurgen Moeller, Siegfried Kasper, Carol Tamminga, Shigeto Yamawaki, Rene Kahn, Rajiv Tandon, Christoph U. Correll, Afzal Javed
CNS Spectrums.2021; 26(6): 562.     CrossRef
Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control
John Anderson, Luigi Meneghini, Debbie Hinnen, Jasvinder Gill, Mathieu Coudert, Pierre Evenou, Medha Munshi
Journal of Diabetes and its Complications.2021; 35(4): 107831.     CrossRef
Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks
Olga V. Saik, Vadim V. Klimontov
International Journal of Molecular Sciences.2021; 22(22): 12419.     CrossRef
Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
Kuan-Chan Chen, Chi-Hsiang Chung, Chieh-Hua Lu, Nian-Sheng Tzeng, Chien-Hsing Lee, Sheng-Chiang Su, Feng-Chih Kuo, Jhih-Syuan Liu, Chang-Hsun Hsieh, Wu-Chien Chien
Journal of Clinical Medicine.2020; 9(3): 660.     CrossRef